Accurate detection of changes in disease activity in primary sjögren's syndrome by the european league against rheumatism sjögren's syndrome disease activity index

Arthritis Care and Research

Volumn 62, Issue 4, 2010, Pages 551-558

  Seror, Raphaèle ^a   Mariette, Xavier ^a   Bowman, Simon ^b   Baron, Gabriel ^a   Gottenberg, Jacques Eric ^c   Boostma, Hendrika ^d   Theander, Elke ^e   Tzioufas, Athanasios ^f   Vitali, Claudio ^g   Ravaud, Philippe ^a  

^a INSERM   (France)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LUND UNIVERSITY   (Sweden)

^f UNIVERSITY OF ATHENS   (Greece)

^g Villamarina Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ACTIVITY; HUMAN; MEDICAL RECORD; PATIENT MONITORING; PHYSICAL ACTIVITY; RHEUMATIC DISEASE; SCORING SYSTEM; SJOEGREN SYNDROME;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 77950378006     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20173     Document Type: Article

References (25)

1. Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sjögren's Syndrome Disease Damage Index and Disease Activity Index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum 2007;56:2223-2231 (Pubitemid 47173570)
2. Bowman SJ, Sutcliffe N, Isenberg DA, Goldblatt F, Adler M, Price E, et al. Sjögren's Systemic Clinical Activity Index (SCAI): a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. Rheumatology (Oxford) 2007;46:1845-1851
3. Seror R, Ravaud P, Bowman S, Baron G, Tzioufas A, Theander E, et al. EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI): development of a consensus systemic disease activity index in primary Sjögren's syndrome. Ann Rheum Dis 2009. E-pub ahead of print.
4. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987;40:171-178
5. Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992;45:1341-1345
6. Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989;42:1097-1105
7. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558 (Pubitemid 34539104)
8. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-458 (Pubitemid 23223653)
9. Barry RJ, Sutcliffe N, Isenberg DA, Price E, Goldblatt F, Adler M, et al. The Sjögren's Syndrome Damage Index: a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome. Rheumatology (Oxford) 2008;47: 1193-1198
10. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160 (Pubitemid 29425900)
11. Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol 2003;56:730-735 (Pubitemid 37040808)
12. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.
13. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
14. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213-220
15. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28:632-642
16. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.
17. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:S178-89.
18. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 4th ed. New York: Oxford University Press; 2008.
19. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000;53:459-468 (Pubitemid 30254341)
20. Agresti A. Categorical data analysis. 2nd ed. New York: John Wiley & Sons; 2002.
21. Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, et al. Do lupus disease activity measures detect clinically important change? J Rheumatol 2000;27:1421-1428
22. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 2004;50:3418-3426
23. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed. New York: Oxford University Press; 1996.
24. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640
25. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29: 288-291